• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Reliance Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/27/25 4:34:02 PM ET
    $RS
    Metal Fabrications
    Industrials
    Get the next $RS alert in real time by email
    false 0000861884 0000861884 2025-05-21 2025-05-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.  20549

     

     

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

     

     

    Date of Report (Date of earliest event reported):

    May 21, 2025

     

     

     

    RELIANCE, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-13122   95-1142616
    (State or other jurisdiction of
    incorporation)
      (Commission File Number)   (I.R.S. Employer
    Identification Number)

     

    16100 N. 71st Street, Suite 400

    Scottsdale, AZ 85254

    (Address of principal executive offices)

     

    (480) 564-5700

    (Registrant’s telephone number, including area code)

     

    Not applicable

    (Former name or former address, if changed since last report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol   Name of each exchange on which registered
    Common stock, $0.001 par value   RS   New York Stock Exchange

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    ¨  Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

     

     

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    (a)On May 21, 2025, Reliance, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) via live webcast. At the Annual Meeting, 47,383,352 shares were represented in person or by proxy, or 89.59% of the total shares outstanding as of the record date for the Annual Meeting.

     

    (b)The Company’s stockholders voted on the matters set forth below:

     

    (1)Each of the nominees for election to the Company’s Board of Directors (the “Board”) were elected to hold office until the Company’s next Annual Meeting of Stockholders, based upon the following votes:

     

    Nominee for director  Votes For   Votes Against   Votes Abstained   Broker Non-Votes 
    Lisa L. Baldwin
       42,075,929    2,052,888    41,171    3,213,364 
    Karen W. Colonias   43,041,391    1,087,443    41,154    3,213,364 
    Frank J. Dellaquila   43,680,585    460,279    29,124    3,213,364 
    James K. Kamsickas   43,762,921    369,145    37,922    3,213,364 
    Karla R. Lewis   43,831,646    298,436    39,906    3,213,364 
    Rpbert A. McEvoy   41,994,418    2,146,512    29,058    3,213,364 
    David W. Seeger   35,891,722    8,248,956    29,310    3,213,364 
    Douglas W. Stotlar   41,851,400    2,289,312    29,276    3,213,364 

     

    (2)The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers was approved based upon the following votes:

     

    The vote was 41,834,604 for; 2,270,934 against; and 64,450 abstentions. There were 3,213,364 broker non-votes.

     

    (3)The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year was approved based upon the following votes:

     

    The vote was 46,845,533 for; 510,088 against; and 27,731 abstentions. There were no broker non-votes.

      

    * * *

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      RELIANCE, INC.
       
    Dated: May 27, 2025 By: /s/ William A. Smith II
        William A. Smith II
        Senior Vice President, General Counsel and Corporate Secretary  

     

    3

     

    Get the next $RS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RS

    DatePrice TargetRatingAnalyst
    1/8/2025Underperform → Peer Perform
    Wolfe Research
    12/2/2024$341.00Neutral
    Goldman
    7/26/2024$262.00Peer Perform → Underperform
    Wolfe Research
    4/11/2024$380.00Buy → Neutral
    Citigroup
    4/28/2023Outperform → Peer Perform
    Wolfe Research
    1/4/2023$231.00Neutral
    BofA Securities
    10/6/2022$218.00 → $201.00Buy → Neutral
    Goldman
    8/15/2022$230.00Outperform
    BMO Capital Markets
    More analyst ratings